Omnaris and Adderall drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omnaris (ciclesonide) and Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate). Common drug interactions include fall among females and aggression among males.

The phase IV clinical study analyzes what interactions people have when they take Omnaris and Adderall. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Omnaris?

Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.

What is Adderall?

Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 64,224 Adderall users. Check the latest studies of Adderall.



On Jul, 29, 2026

41 people who take Omnaris and Adderall together, and have interactions are studied.

Omnaris and Adderall drug interactions.

What are the common drug interactions of Omnaris and Adderall, by gender? *:

female:

  1. Fall
  2. Peripheral swelling
  3. Fatigue (feeling of tiredness)
  4. Pain
  5. Disturbance in attention
  6. Hypertension (high blood pressure)
  7. Memory impairment
  8. Parasomnia (sleep disorders that involve abnormal and unnatural movements, behaviours, emotions, perceptions)
  9. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  10. Stress

male:

  1. Aggression
  2. Lacunar infarction (a type of stroke)
  3. Memory impairment
  4. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  5. Pneumonia
  6. Pyrexia (fever)
  7. Respiratory tract infection
  8. Spontaneous penile erection (sudden penis tightness)
  9. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  10. Diplopia (double vision)

What are the common drug interactions of Omnaris and Adderall, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal discomfort
  2. Abdominal distension
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Hypersensitivity
  7. Infusion site erythema (reddening of the skin at infusion site)
  8. Oesophagitis (inflammation of oesophagus)
  9. Pharyngeal inflammation
  10. Pharyngitis streptococcal (inflammation of the pharynx caused by infection from. streptococcus)

40-49:

  1. Diplopia (double vision)
  2. Influenza like illness
  3. Injection site dryness
  4. Injection site erythema (redness at injection site)
  5. Injection site inflammation
  6. Injection site swelling
  7. Memory impairment
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)

50-59:

  1. Aggression
  2. Lacunar infarction (a type of stroke)
  3. Spontaneous penile erection (sudden penis tightness)
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Pyrexia (fever)
  6. Respiratory tract infection
  7. Wrist surgery

60+:

  1. Fall
  2. Joint injury
  3. Nausea (feeling of having an urge to vomit)
  4. Pain in extremity
  5. Post procedural complication
  6. Vomiting
  7. Weight decreased
  8. Knee arthroplasty
  9. Pain
  10. Back pain

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 29 people, 70.73%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 36.59%
  3. Pain: 3 people, 7.32%
  4. Muscle Spasms (muscle contraction): 3 people, 7.32%
  5. Multiple Allergies (allergy to multiple agents): 3 people, 7.32%
  6. Immunodeficiency Common Variable: 3 people, 7.32%
  7. Dry Eyes (lack of adequate tears): 3 people, 7.32%
  8. Blood Potassium Decreased: 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Omnaris and Adderall?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omnaris and Adderall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omnaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Adderall:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omnaris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Adderall and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciclesonide and amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate (the active ingredients of Omnaris and Adderall, respectively), and Omnaris and Adderall (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: